A Pilot Study of a Heparin Dosing Algorithm for Hemodialysis
| Status: | Archived |
|---|---|
| Conditions: | Renal Impairment / Chronic Kidney Disease |
| Therapuetic Areas: | Nephrology / Urology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | March 2011 |
| End Date: | October 2011 |
Heparin Dose Reduction During Hemodialysis With the Gambro Revaclear and Revaclear MAX Hemodialyzers: A Pilot Study
During hemodialysis treatments, patients receive heparin to prevent clotting. The purpose
of this pilot study is to determine if the amount of heparin administered during a patient's
hemodialysis can be individualized using an equation for heparin dose adjustment.
We found this trial at
1
site
University of Louisville Hospital As the academic hospital at the heart of the Louisville Metro...
Click here to add this to my saved trials
